Tardive dyskinesia in Tourette syndrome.

Abstract

Three patients are reported who developed oral-buccal-lingual movements typical of tardive dyskinesia while being treated with stable doses of haloperidol for Tourette syndrome. In each case signs resolved within a number of weeks after medication was discontinued. One of the patients experienced recurrence of the dyskinesia during a challenge with phenothiazine tranquilizers. In each case the dose of haloperidol was well within the usual therapeutic range. A strong family history of movement disorders, including Tourette syndrome, was present in each family.

• Authors: G S Golden
• Journal: Pediatric neurology (Pediatr Neurol) 1985 May-Jun Vol. 1 Issue 3 Pg. 192-4 ISSN: 0887-8994 [Print] United States
• PMID: 3880404 (Publication Type: Case Reports, Journal Article)

Chemical References

• Haloperidol

Topics

• Adolescent
• Adult
• Dyskinesia, Drug-Induced (etiology)
• Female
• Haloperidol (adverse effects, therapeutic use)
• Humans
• Male
• Tourette Syndrome (drug therapy, genetics)